Conference Coverage

Vascular disease linked to sight loss in giant cell arteritis

Publish date: May 10, 2016

 

AT RHEUMATOLOGY 2016

References

The DCVAS study is supported by the ACR and is funded by the European League Against Rheumatism and the Vasculitis Foundation. Dr. Yates reported that he had no relevant disclosures.

Pages

Recommended Reading

ACR: First U.S. clinical practice guidelines arise for Sjögren’s syndrome management
MDedge Internal Medicine
EADV: DLX105 is a novel treatment strategy for Behçet’s flares
MDedge Internal Medicine
Axis I psychiatric disorders high in skin-restricted lupus patients
MDedge Internal Medicine
End-stage renal disease risk in lupus nephritis remains unchanged of late
MDedge Internal Medicine
New tool better predicts coronary artery disease in lupus patients
MDedge Internal Medicine
Low incidence, mortality described for mixed connective tissue disease
MDedge Internal Medicine
Getting a leg up on bone comorbidities in lupus
MDedge Internal Medicine
Lupus patients’ transition to adult care leaves gaps, delays in care
MDedge Internal Medicine
Small fiber neuropathy common, vexing in sarcoidosis
MDedge Internal Medicine
Tofacitinib an alternative treatment for refractory cutaneous dermatomyositis
MDedge Internal Medicine